The favourable effect of cyclophosphamide in myasthenia gravis.
D000328:Adult; D001323:Autoantibodies; D001327:Autoimmune Diseases; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D009157:Myasthenia Gravis / Q000188:drug therapy*; D013934:Thymectomy; D013953:Thymus Neoplasms / Q000150:complications
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide